-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
Jw5CD2is8PZA9C8zhSn76ynSD6CDCvjUX5DL+JzGvYCTWHlbqlu9q0RstwfHGuas
NOrkUFKziNBXOLdI5i8XMg==
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Date of Report: December 8, 2003
HUMANA INC.
Delaware |
1-5975 |
61-0647538 |
500 West Main Street
Louisville, KY 40202
(Address of principal executive offices, including zip code)
(502) 580-1000
(Registrant's telephone number, including area code)
Item 5. Other Events.
On December 8, 2003, Humana Inc. (the "Company") issued a press release, a copy of which is attached hereto as Exhibit 99 and is incorporated herein by reference, concerning the recently signed legislative reform for the Medicare program.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HUMANA INC. |
BY: /s/ Arthur P. Hipwell |
Date: December 8, 2003
INDEX TO EXHIBITS
Number Description
99 Press Release, dated December 8, 2003, issued by the Company
Humana Inc.
500 West Main Street
P.O. Box 1438
Louisville, KY 40201-1438
www.humana.com
news
releaseFor More Information Contact:
Regina Nethery
Humana Investor Relations
(502) 580-3644
E-mail: rnethery@humana.com
Tom Noland
Humana Corporate Communications
(502) 580-3674
E-mail: tnoland@humana.com
Humana Inc. Comments on Impact of Medicare Reform
LOUISVILLE, KY (December 8, 2003) - Humana Inc. (NYSE: HUM) announced today that, in light of recently signed legislative reform for the Medicare program, the company is reevaluating its guidance for 2004 earnings.
The Medicare reform legislation also includes provisions that may provide longer-term opportunities for Humana. These include the potential to (1) expand the company's current Medicare+Choice market presence (2) become a Medicare Advantage Regional PPO, (3) add an Interim Drug Discount Card, and (4) become a Prescription Drug Standalone Plan. The company is evaluating these potential opportunities and any related impact upon its longer-term financial position, results of operations, or cash flows and anticipates completing its analysis during the first half of 2004.
"We commend President Bush and Congress on recognizing the need for stabilization funding for the Medicare+Choice program, as well as providing a prescription drug benefit and additional private plan options for seniors," said Michael B. McCallister, Humana's president and chief executive officer. "We believe this is a significant step in providing a long-term foundation for the Medicare Advantage program, thus ensuring that today's and tomorrow's seniors have the same kinds of private plan health benefit options people under 65 years of age experience."
The Medicare reform bill includes provisions that require 2004 stabilization funding be directed towards increased reimbursement for providers, increased benefits or access for members, or decreased member premiums. Given these parameters, the company does not anticipate the benefit to its 2004 earnings to be significant.
The company anticipates the Centers for Medicare and Medicaid Services to publish its revised 2004 Medicare rate book in January 2004. Related regulatory filings by the company in response to the new rate book must be submitted and approved prior to a final determination of the impact of the legislation upon the company's 2004 earnings guidance. Plan changes associated with the company's revised filings are expected to become effective March 1, 2004. Accordingly, the specific impact of Medicare reform legislation upon 2004 earnings will not be determinable until the first quarter of 2004.
***********
This news release contains forward-looking statements. The forward-looking statements made in the news release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described in the following documents, as filed by Humana with the Securities and Exchange Commission:
***********
Humana Inc., headquartered in Louisville, Kentucky, is one of the nation's largest publicly traded health benefits companies, with approximately 6.6 million medical members located primarily in 18 states and Puerto Rico. Humana offers coordinated health insurance coverage and related services - through traditional and Internet-based plans - to employer groups, government-sponsored plans, and individuals.
More information regarding Humana is available via the Internet at www.humana.com, including copies of: